Oral administration
Phase 2Small molecule
Oral administration is one of 33 small molecule programs targeting Endometritis. It is currently in Phase 2.
2
Indications
2
Total Trials
0
Active Trials
32
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
165 competitors in Anxiety
#DrugCompanyPhaseTrials
1Circadin
NNeurim Pharmaceuticals Ltd.
Phase 3
Celexa
AbbViePreclinical
Spravato
WWim Janssens
Preclinical
Campral
FForest Laboratories
Preclinical
Luvox
SSolvay Pharmaceuticals
Preclinical
Anerem
AAcacia Pharma Ltd
Preclinical
Oral administration
BBiomind Labs Inc.
Phase 2
Sufenta
LLeaf Vertical Inc.
Preclinical
Catapres
Boehringer IngelheimPreclinical
Andriol
AAuxilium
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Oral administration. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- BBiomind Labs Inc.